Two early-phase study trials suggest that GSK’s RSV vaccine, Arexvy, may benefit certain high-risk subgroups of younger adults and could potentially serve a broader...
Two medications have been shown to drastically alter the prognosis for the fatal skin disease melanoma, according to information gained through a decade of...
AstraZeneca announced that its new weight-loss medication, which was licensed from Eccogene of China, underwent early-stage testing and was found to be safe and...
Apellis Pharmaceuticals and Novartis recently shared data for their rare kidney disease drugs, pegcetacoplan and iptacopan. Both have performed well in treating C3 glomerulopathy...
Marinus Pharmaceuticals, a pharmaceutical company, has been dealt a blow after its Seizure drug, Ztalmy, did not reach the primary endpoint in the phase...
The latest research on Arcus Biosciences' experimental HIF-2a inhibitor suggests that the firm may provide significant competition to Merck's Welireg in treating kidney cancer.
In...
In a nuclear medicine surge, industry leader Orano Med has selected the U.S. as a production site for further radiopharma development. Orano Med, which...
Gerresheimer, the maker of innovative systems and solutions and a partner to the pharma, biotech, and cosmetics industries, is increasing the production capacity of...
Novo Nordisk, a prominent player in the pharmaceutical industry, is commemorating three decades of operations in China, coinciding with the potential approval of its...
In exchange for $285 million, Copenhagen-based Ascendis has agreed to help Novo Nordisk develop a once-a-month GLP-1 receptor antagonist and has granted a license...
AbbVie has agreed to spend $1.4 billion to purchase Aliada Therapeutics. Through this acquisition, AbbVie will be able to build upon the first class...
Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal imbalances, resulting in irregular weight patterns. Wisp’s new weight care...
Health technology company PicnicHealth has launched a new product, Virtual Site, which allows researchers to carry out clinical trials remotely. This innovation is targeted...
Neuralink, founded by Elon Musk, revealed that it has placed its device in the second human trial subject. The therapeutic application of the technology...
In 2024, megarounds have been extremely uncommon. Nonetheless, Formation Bio was able to secure a remarkable series D funding round of $372 million as...
The Food and Drug Administration (FDA) has recently granted approval to Swiss company Roche’s inavolisib for treating HR-positive, HER2-negative breast cancer. The treatment has...
The FDA gave the green light to Bristol Myers Squibb’s much-anticipated schizophrenia drug Cobenfy, the first new chemical entity to treat the severe, chronic...
In a decision expected to limit Brussels' merger authority, American gene sequencing firm Illumina prevailed in court against the European Union's inquiry into its...
Regulators around the world are increasing their scrutiny of medical devices as these become more critical to patient outcomes. Referencing new research, Peter Muller...
Ensuring a patient centric approach during clinical research is vitally important to research sponsors and their partners. A clinical research site that...
Science fiction author Arthur C. Clarke once commented that “Any sufficiently advanced technology is indistinguishable from magic.” Over the last couple of...
Two early-phase study trials suggest that GSK’s RSV vaccine, Arexvy, may benefit certain high-risk subgroups of younger adults and could potentially serve a broader...
Two medications have been shown to drastically alter the prognosis for the fatal skin disease melanoma, according to information gained through a decade of...
AstraZeneca announced that its new weight-loss medication, which was licensed from Eccogene of China, underwent early-stage testing and was found to be safe and...
Apellis Pharmaceuticals and Novartis recently shared data for their rare kidney disease drugs, pegcetacoplan and iptacopan. Both have performed well in treating C3 glomerulopathy...
Marinus Pharmaceuticals, a pharmaceutical company, has been dealt a blow after its Seizure drug, Ztalmy, did not reach the primary endpoint in the phase...
The latest research on Arcus Biosciences' experimental HIF-2a inhibitor suggests that the firm may provide significant competition to Merck's Welireg in treating kidney cancer.
In...
In a nuclear medicine surge, industry leader Orano Med has selected the U.S. as a production site for further radiopharma development. Orano Med, which...
Gerresheimer, the maker of innovative systems and solutions and a partner to the pharma, biotech, and cosmetics industries, is increasing the production capacity of...
Novo Nordisk, a prominent player in the pharmaceutical industry, is commemorating three decades of operations in China, coinciding with the potential approval of its...
In exchange for $285 million, Copenhagen-based Ascendis has agreed to help Novo Nordisk develop a once-a-month GLP-1 receptor antagonist and has granted a license...
AbbVie has agreed to spend $1.4 billion to purchase Aliada Therapeutics. Through this acquisition, AbbVie will be able to build upon the first class...
Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal imbalances, resulting in irregular weight patterns. Wisp’s new weight care...
Health technology company PicnicHealth has launched a new product, Virtual Site, which allows researchers to carry out clinical trials remotely. This innovation is targeted...
Neuralink, founded by Elon Musk, revealed that it has placed its device in the second human trial subject. The therapeutic application of the technology...
In 2024, megarounds have been extremely uncommon. Nonetheless, Formation Bio was able to secure a remarkable series D funding round of $372 million as...
The Food and Drug Administration (FDA) has recently granted approval to Swiss company Roche’s inavolisib for treating HR-positive, HER2-negative breast cancer. The treatment has...
The FDA gave the green light to Bristol Myers Squibb’s much-anticipated schizophrenia drug Cobenfy, the first new chemical entity to treat the severe, chronic...
In a decision expected to limit Brussels' merger authority, American gene sequencing firm Illumina prevailed in court against the European Union's inquiry into its...
Regulators around the world are increasing their scrutiny of medical devices as these become more critical to patient outcomes. Referencing new research, Peter Muller...
Ensuring a patient centric approach during clinical research is vitally important to research sponsors and their partners. A clinical research site that...
Science fiction author Arthur C. Clarke once commented that “Any sufficiently advanced technology is indistinguishable from magic.” Over the last couple of...